🚨NIH and DoD Ink $6.6B Medical Research Deal
NIH funds DoD projects it won't touch
TL;DR
The NIH and DoD have struck a deal to fund medical countermeasures with $6.6B from the NIH's NIAID budget. The agreement, signed a month early, faces uncertainty over future Congressional approval.
The NIH and DoD have inked a $6.6B deal for medical countermeasure research, using funds from the NIH's NIAID budget. This agreement, signed a month before its public release, allows the DoD to fund projects and staff that the NIH won't support. The NIH has been struggling to allocate its full budget, while the DoD faces budget constraints due to ongoing conflicts. The deal's vagueness and potential Congressional pushback make its long-term impact uncertain. This is a big deal for researchers and policymakers navigating federal funding.
Key Points
NIH and DoD signed a deal to fund medical countermeasures with $6.6B from NIH's NIAID budget.
The agreement was signed a month before its public release, raising questions about transparency.
The DoD aims to fund projects and staff supporting medical countermeasures, a priority under budget strain.
NIH faces challenges in issuing grants, leading to unused funds and the DoD's interest in NIH funding.
Future Congresses may restrict this type of spending, adding uncertainty to the agreement's longevity.
Why It Matters
The NIH and DoD's $6.6B agreement redirects NIH funds to DoD projects, bypassing NIH's funding priorities. This impacts researchers seeking NIH grants and DoD's ability to fund critical medical countermeasures. The deal's future is uncertain, with potential Congressional restrictions looming.
Frequently Asked Questions
Why does this matter?
The NIH and DoD's $6.6B agreement redirects NIH funds to DoD projects, bypassing NIH's funding priorities. This impacts researchers seeking NIH grants and DoD's ability to fund critical medical countermeasures. The deal's future is uncertain, with potential Congressional restrictions looming.
What happened?
The NIH and DoD have struck a deal to fund medical countermeasures with $6.6B from the NIH's NIAID budget. The agreement, signed a month early, faces uncertainty over future Congressional approval.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,470 builders reading daily.